{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidyjhhgs5mj324m6ovsjnzeejacgdxcx6wykamc35bkf7z4tcscui",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mg46xfx265z2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic3vhilyoizztgxbazyxjidfebwl465gotztqnudbed3dnow2eycu"
    },
    "mimeType": "image/jpeg",
    "size": 320129
  },
  "path": "/news/2026-03-molecular-pancreatic-cancer-treatable.html",
  "publishedAt": "2026-03-02T15:20:07.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Oncology & Cancer"
  ],
  "textContent": "Scientists at Duke-NUS Medical School have identified a molecular \"switch\" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some of the most treatment-resistant tumors into forms that are more manageable with existing drugs.",
  "title": "A molecular 'switch' could make pancreatic cancer more treatable"
}